Medicamen Biotech Limited (MEDICAMEQ) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE646B01010
Key metrics
- Market Cap
- ₹364 Cr
- P/E Ratio
- 36.23
- EPS
- 7.41
- Book Value
- 203.17
- P/B Ratio
- 1.32
- ROE
- 3.5%
- ROCE
- 3.83%
- Debt / Equity
- 0.17
- Net Margin
- 4.88%
- Revenue Growth
- 21.67%
- Profit Growth
- 35.64%
- Dividend Yield
- 0.37%
- 52W High
- ₹447.65
- 52W Low
- ₹212.40
- Market Cap Band
- micro cap
- Face Value
- 10
Ratios computed from the annual results period ending 2026-03-31.
About Medicamen Biotech Limited
Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, syrups, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-malarials, vitamins, antibiotics, and supplements, other generics, and pain management. The company was incorporated in 1993 and is based in New Delhi, India.
- Headquarters
- New Delhi, India
- Promoter Holding
- 62.97%
The full Medicamen Biotech Limited analysis
Create a free account to open the complete MEDICAMEQ deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.